| Application no. and date | 00938074.2 (espacenet) (Federated) (European Patent Register), 20000602 | | Patent/reg. no. and date | DK/EP 1183020, 20060816 | | Publication date | 20020306 | | Priority no. and date | US 325997, 19990604 | | EP pub. no. and date |
EP 1183020 20020306 | | Effective date | | | Applicant/owner | Diatex, Inc., 105 Elm Spring Lane
San Antonio, TX 78231, US,
CymaBay Therapeutics, Inc., 7999 Gateway Blvd, Suite 130
Newark, CA 94560, US | | Applicant ref. no. | P40730DK01 | | Inventor | LUSKEY, Kenneth, L., 21185 Toll Gate Road
Saratoga, CA 95070, US,
LUO, Jian, 240 Klamath Street
Brisbane, CA 94005, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61P 3/10 (2006.01) | | Title | (3-trihalogenmethylphenoxy)(4-halogenphenyl) til behandling af insulinresistens og type 2-diabetes | | Int. application no. | US2000015235 | | Int. publication no. | WO2000074666 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
